$KALV·4

Carbylan Therapeutics, Inc. · Jan 5, 4:05 PM ET

Carbylan Therapeutics, Inc. 4

4 · Carbylan Therapeutics, Inc. · Filed Jan 5, 2016

Insider Transaction Report

Form 4
Period: 2016-01-04
McKune John
See Remarks
Transactions
  • Award

    Stock Option (Right to buy)

    2016-01-04+10,00010,000 total
    Exercise: $3.33Exp: 2026-01-04Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option shall vest with respect to 1/48 of the underlying shares upon each monthly anniversary of the vesting commencement date of January 1, 2016.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION